In Vitro Effects of ATG-Fresenius on Immune Cell Adhesion

被引:5
作者
Kanzler, I. [1 ]
Seitz-Merwald, I. [2 ]
Schleger, S. [3 ]
Kaczmarek, I. [3 ]
Kur, F. [3 ]
Beiras-Fernandez, A. [1 ]
机构
[1] JW Goethe Univ Hosp, Dept Cardiothorac & Vasc Surg, D-61590 Frankfurt, Germany
[2] Fresenius Biotech GmbH, Grafelfing, Germany
[3] Univ Munich, Dept Cardiac Surg, Munich, Germany
关键词
ANTI-THYMOCYTE GLOBULINS; ANTITHYMOCYTE GLOBULINS; MOLECULES; VISUALIZATION; ANTIBODIES; ISCHEMIA;
D O I
10.1016/j.transproceed.2013.01.079
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
071005 [微生物学]; 100108 [医学免疫学];
摘要
Introduction. ATG-Fresenius, a purified rabbit polyclonal anti-human T-lymphocyte immunoglobulin is used for induction immunosuppression as well as prevention and treatment of acute rejection episodes among patients receiving solid organ transplants. The aim of this study was to investigate the in vitro activity of ATG-Fresenius upon immune cell adhesion, which may explain its activity to mitigate ischemia-reperfusion injury. Materials and methods. Human vascular endothelial cells (HUVEC) and peripheral blood mononuclear cells (PBMCs) isolated from umbilical vein or peripheral blood were incubated 20 to 24 hours before analysis. HUVEC were incubated with 10 and 100 mu g/mL ATG-Fresenius or reference polyclonal rabbit immunoglobulin G. Analysis of immune cell adhesion to endothelial cells was studied in cocultures of PBMCs and adherent HUVEC. Endothelial cell expression of adhesion molecules CD62E and CD54 was determined by flow cytometry. The numbers of T-, B- and natural killer cells attached to HUVEC were also determined by flow cytometry. Groups were compared using one-way analysis of variance. Results. We showed that ATG-Fresenius binds to endothelial cells particularly activated ones expressing increased levels of E-selectin and ICAM-1. The increased binding of ATG-Fresenius to activated endothelial cells was consistent with its known binding to Intercellular Adhesion Molecule 1 (ICAM-1) and selectins. We also showed that ATG-Fresenius inhibited adhesion of prestimulated immune cells to activated endothelium. Conclusion. We demonstrated dose-dependent binding of ATG-Fresenius to activated endothelial cells.
引用
收藏
页码:1846 / 1849
页数:4
相关论文
共 14 条
[1]
Beiras-Fernandez A, 2003, Exp Clin Transplant, V1, P79
[2]
Polyclonal anti-thymocyte globulins influence apoptosis in reperfused tissues after ischaemia in a non-human primate model [J].
Beiras-Fernandez, A ;
Thein, E ;
Chappel, D ;
Gallego, R ;
Fernandez-Roel, D ;
Kemming, G ;
Hammer, C .
TRANSPLANT INTERNATIONAL, 2004, 17 (08) :453-457
[3]
Impact of polyclonal anti-thymocyte globulins on the expression of adhesion and inflammation molecules after ischemia-reperfusion injury [J].
Beiras-Fernandez, A. ;
Chappell, D. ;
Hammer, C. ;
Beiras, A. ;
Reichart, B. ;
Thein, E. .
TRANSPLANT IMMUNOLOGY, 2009, 20 (04) :224-228
[4]
Antithymocyte Globulins Bind to Human Umbilical Vein Endothelial Cells [J].
Beiras-Fernandez, A. ;
Walther, S. ;
Csapo, C. ;
Muenzing, S. ;
Hammer, C. ;
Reichart, B. ;
Thein, E. .
TRANSPLANTATION PROCEEDINGS, 2009, 41 (06) :2286-2288
[5]
Beiras-Fernandez Andres, 2005, Exp Clin Transplant, V3, P370
[6]
ANTIBODIES AGAINST FUNCTIONAL LEUKOCYTE SURFACE MOLECULES IN POLYCLONAL ANTILYMPHOCYTE AND ANTITHYMOCYTE GLOBULINS [J].
BONNEFOYBERARD, N ;
VINCENT, C ;
REVILLARD, JP .
TRANSPLANTATION, 1991, 51 (03) :669-673
[7]
In vivo visualization of the effect of polvclonal antithymocyte globulins on the microcirculation after ischemia/reperfusion in a primate model [J].
Chappell, D ;
Beiras-Fernandez, A ;
Hammer, C ;
Thein, E .
TRANSPLANTATION, 2006, 81 (04) :552-558
[8]
GROSSEWILDE H, 1981, P EUR DIAL TRANS, V18, P481
[9]
Visualization of the effect of polyclonal antithymocyte globulins on adhesion of leukocytes [J].
Hammer, C ;
Thein, E .
TRANSPLANTATION PROCEEDINGS, 2002, 34 (06) :2486-2487
[10]
Functional antibodies to leukocyte adhesion molecules in antithymocyte globulins. [J].
Michallet, MC ;
Preville, X ;
Flacher, M ;
Fournel, S ;
Genestier, L ;
Revillard, JP .
TRANSPLANTATION, 2003, 75 (05) :657-662